aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer

Reporter: J Taylor Whaley, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de junio del 2013

Translation for this article does not exist


Breast Cancer Survivorship: A Roadmap
by OncoLink Editorial Team
August 20, 2013

Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015